Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 25 (6) , 101183
Abstract
No abstract availableKeywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD071594)
This publication has 66 references indexed in Scilit:
- Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2Areceptor knockout mice with microarray profilingPhysiological Genomics, 2009
- G protein coupled receptor structure and activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Caffeine Metabolism in Premature InfantsThe Journal of Clinical Pharmacology, 2001
- Theophylline versus caffeine: Comparative effects in treatment of idiopathic apnea in the preterm infantThe Journal of Pediatrics, 1987
- Theophylline Pooled Michaelis-Menten Parameters (Vmax and Km) and ImplicationsClinical Pharmacokinetics, 1985
- Chronic caffeine consumption increases the number of brain adenosine receptorsLife Sciences, 1983
- The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infantsThe Journal of Pediatrics, 1981
- Metabolism of theophylline to caffeine in premature newborn infantsThe Journal of Pediatrics, 1979
- Pharmacokinetic profile of caffeine in the premature newborn infant with apneaThe Journal of Pediatrics, 1979
- Efficacy of caffeine in treatment of apnea in the low-birth-weight infantThe Journal of Pediatrics, 1977